Countdown commences: Shares of Allianz and BASF under scrutiny in the upcoming days
Preparing for Q1 Earnings: Allianz and BASF's Q4 2024 Results
The financial landscapes of Allianz and BASF will come into sharper focus in a matter of days, as both companies are set to reveal their Q4 2024 earnings on February 28, 2025. As their stocks continue to perform well, investors are left to decide whether to buy, hold, or sell ahead of these crucial releases.
Allianz's Steady Ascent
Allianz's stock has been on a steady upward trajectory, showing remarkable growth over the past year. The company's quarterly results are expected to reflect this positive trend, with earnings per share forecasted to increase from €6.00 in the previous year to €6.38. Full-year 2024 earnings are projected to reach €25.38, up from €21.20 in the previous year. The dividend is also predicted to rise from €11.40 to €13.80.
Despite the positive outlook, the potential for a correction is always present, given how far Allianz's stock has risen. Investors may want to take advantage of any dips in the 50-day line before purchasing. BÖRSE ONLINE maintains its buy recommendation for Allianz, with a price target of €350.
BASF's Turnaround and Recovery
BASF's turnaround appears to be underway, thanks in part to hopes for a ceasefire in Ukraine. The stock has recently surged past the crucial 200-day line, but it must overcome its last local high of €54.50 to ensure the bottoming process is complete. The upcoming earnings report will offer significant insight into the company's progress. Analysis suggests earnings per share will be €0.154, marking a stark contrast to the loss of €1.78 in the previous year.
Revenue is projected to decline slightly from €15.87 billion to €15.56 billion, but investors should keep an eye on developments in Ukraine and BASF's divestments. Despite these challenges, BÖRSE ONLINE still encourages investors to buy BASF stock, with a price target of €61.80. Given the formation of a golden cross, indicating a potential continuation of the uptrend, it may be wise to stay the course and consider small pullbacks as an opportunity to buy in.
For more insights, read "The Return of Swiss Stocks: Anticipation Builds Starting This Date"
Evaluating Enrichment Data
Analyzing recent performance trends and challenges, Allianz's strong momentum and fundamentally solid story could make it valuable despite a neutral rating from major analysts and the recent surge in share price. In contrast, BASF faces negative earnings momentum and challenges, leading to a "hold" rating, making a cautious approach necessary for investors.
In summary, investors should adopt caution when considering Allianz due to its recent price rise and neutral rating. For BASF, a more calculated approach is advised, with a wait-and-see strategy until there is evidence of a turnaround following the upcoming quarterly results. It's crucial to monitor key indicators, such as volume recovery, improved margins, or positive guidance, before adjusting investment positions.
- In the context of Allianz's steady growth, investors might choose to be wary of any potential corrections, given the stock's upward trajectory, and may consider purchasing when there are dips near the 50-day line.
- BASF's turnaround seems to be progressing, with earnings recovering from a loss in the previous year. However, investors should be mindful of challenges like the situation in Ukraine and the company's divestments before making buying decisions, as suggested by the formation of a golden cross indicating an uptrend.
- Although Allianz has a strong financial story and growth momentum, its recent price surge and neutral rating from major analysts warrant careful consideration from investors. Meanwhile, the negative earnings momentum and challenges faced by BASF lead to a "hold" rating, suggesting a cautious approach for potential investors.
